Contact this trialFirst, we need to learn more about you.
Belantamab mafodotin for Multiple Myeloma
Recruiting2 awardsPhase 3
Atlanta, Georgia
This trial is for people who have received or are currently receiving treatment with belantamab mafodotin for multiple myeloma. The purpose is to get a better understanding of the corneal events seen in some patients receiving this treatment. A small piece of the superficial corneal epithelial tissue will be removed and studied. The trial will last for 4 months and involve 25 patients.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.